- Home
- YETI vs AAPG Comparison
YETI vs AAPG Comparison
Compare YETI & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YETI
- AAPG
- Stock Information
- Founded
- YETI 2006
- AAPG 2009
- Country
- YETI United States
- AAPG China
- Employees
- YETI N/A
- AAPG 567
- Industry
- YETI Recreational Games/Products/Toys
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- YETI Consumer Discretionary
- AAPG Health Care
- Exchange
- YETI Nasdaq
- AAPG Nasdaq
- Market Cap
- YETI 2.4B
- AAPG 2.2B
- IPO Year
- YETI 2018
- AAPG 2025
- Fundamental
- Price
- YETI $30.55
- AAPG $24.40
- Analyst Decision
- YETI Buy
- AAPG Buy
- Analyst Count
- YETI 15
- AAPG 1
- Target Price
- YETI $39.79
- AAPG N/A
- AVG Volume (30 Days)
- YETI 3.1M
- AAPG 14.1K
- Earning Date
- YETI 05-08-2025
- AAPG 06-10-2025
- Dividend Yield
- YETI N/A
- AAPG N/A
- EPS Growth
- YETI 4.22
- AAPG N/A
- EPS
- YETI 2.08
- AAPG N/A
- Revenue
- YETI $1,839,607,000.00
- AAPG $134,352,180.00
- Revenue This Year
- YETI $5.03
- AAPG N/A
- Revenue Next Year
- YETI $5.52
- AAPG $389.09
- P/E Ratio
- YETI $14.67
- AAPG N/A
- Revenue Growth
- YETI 8.38
- AAPG 341.77
- 52 Week Low
- YETI $26.61
- AAPG $16.50
- 52 Week High
- YETI $45.25
- AAPG $26.55
- Technical
- Relative Strength Index (RSI)
- YETI 51.84
- AAPG N/A
- Support Level
- YETI $29.16
- AAPG N/A
- Resistance Level
- YETI $31.55
- AAPG N/A
- Average True Range (ATR)
- YETI 1.07
- AAPG 0.00
- MACD
- YETI 0.01
- AAPG 0.00
- Stochastic Oscillator
- YETI 41.53
- AAPG 0.00
About YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.